2024-07-15 11:42:36 ET
Summary
- Intuitive Surgical's revenue and EPS for Q1 beat estimates, and the stock has risen 17% since the last earnings preview.
- The release of the da Vinci 5 robotic system is expected to boost sales by encouraging upgrades among current users.
- Analysts expect Q2 EPS of $1.54 and revenue of $1.97 billion, with a focus on procedure growth and new system placements.
- Intuitive Surgical’s financial health is robust, with a strong balance sheet and significant cash flow from operations.
- The investment recommendation is to buy ISRG stock, particularly on volatility-induced price dips.
Introduction
Read the full article on Seeking Alpha
For further details see:
Intuitive Surgical Q2 Earnings Preview: Near-Term Volatility, Long-Term Growth